Meta facebook tracking pixel

Listen Now

Topics Covered

  • Overview of Non-Hodgkin Lymphoma (NHL)
  • Signs & Symptoms, in the Context of COVID-19
  • NHL Staging & Subtypes
  • Indolent & Aggressive
  • Relapsed & Refractory NHL
  • Novel Treatment Approaches
  • The Role of Clinical Trials
  • How Research Adds to Your Treatment Options
  • Your Comfort Level with Adherence
  • Managing Treatment Side Effects, in the Context of COVID-19
  • Communicating with Your Health Care Team about Quality-of-Life Concerns
  • Follow-Up Care Appointments
  • The Increasing Role of Telehealth & Telemedicine Appointments
  • Guidelines to Prepare for Telehealth/ Telemedicine Appointments, including Technology & List of Questions
  • Questions for Our Panel of Experts

Our Panel of Experts


Ajay K. Gopal, MD

Professor of Medicine, Division of Medical Oncology, University of Washington, Member, Clinical Research Division, Fred Hutchinson Cancer Research Center, Clinical Research Director and Associate Medical Director, Hematology and Hematologic Malignancies, Seattle Cancer Care Alliance


Andrew M. Evens, DO, MSc, FACP

Professor of Medicine, Rutgers Robert Wood Johnson Medical School, Associate Director for Clinical Services, Rutgers Cancer Institute of New Jersey, Director, Lymphoma Program, Division of Blood Disorders, Medical Director, Oncology Service Line, RWJBarnabas Health


Thomas M. Habermann, MD

Professor of Medicine, Mayo Clinic College of Medicine


Carolyn Messner, DSW, BCD, FAPOS, FAOSW

Director of Education and Training, CancerCare


You can download the brochure for this workshop Download button

Workshop Date

This workshop was originally recorded on May 20, 2021.

Search by:



The information presented in this workshop is provided for your general information only. It is not intended as medical advice and should not be relied upon as a substitute for consultations with qualified health professionals who are aware of your specific situation. We encourage you to take information and questions back to your individual health care provider as a way of creating a dialogue and partnership about your cancer and your treatment.

Back to Top

Terms of Use and Privacy Policy

By using our website, you agree to our recently updated Privacy Policy . Here you can read more about our use of cookies which help us make continuous improvements to our website. Privacy Policy.